BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 29914796)

  • 1. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
    Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
    Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical tolerance of corticospinal tracts in convection-enhanced delivery to the brainstem.
    Morgenstern PF; Zhou Z; Wembacher-Schröder E; Cina V; Tsiouris AJ; Souweidane MM
    J Neurosurg; 2018 Dec; 131(6):1812-1818. PubMed ID: 30579270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma.
    Luther N; Zhou Z; Zanzonico P; Cheung NK; Humm J; Edgar MA; Souweidane MM
    Neuro Oncol; 2014 Jun; 16(6):800-6. PubMed ID: 24526309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma.
    Bander ED; Ramos AD; Wembacher-Schroeder E; Ivasyk I; Thomson R; Morgenstern PF; Souweidane MM
    J Neurosurg Pediatr; 2020 Sep; 26(6):661-666. PubMed ID: 32977309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
    Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial.
    McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP
    J Neurosurg Pediatr; 2021 Aug; 28(4):371-379. PubMed ID: 34359048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.
    Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM
    J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deformational changes after convection-enhanced delivery in the pediatric brainstem.
    Bander ED; Tizi K; Wembacher-Schroeder E; Thomson R; Donzelli M; Vasconcellos E; Souweidane MM
    Neurosurg Focus; 2020 Jan; 48(1):E3. PubMed ID: 31896089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.
    Guisado DI; Singh R; Minkowitz S; Zhou Z; Haque S; Peck KK; Young RJ; Tsiouris AJ; Souweidane MM; Thakur SB
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1367-73. PubMed ID: 26939629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma.
    Mueller S; Kline C; Stoller S; Lundy S; Christopher L; Reddy AT; Banerjee A; Cooney TM; Raber S; Hoffman C; Luks T; Wembacher-Schroeder E; Lummel N; Zhang Y; Bonner ER; Nazarian J; Molinaro AM; Prados M; Villanueva-Meyer JE; Gupta N
    Neuro Oncol; 2023 Nov; 25(11):2074-2086. PubMed ID: 37318058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.
    Thompson EM; Landi D; Brown MC; Friedman HS; McLendon R; Herndon JE; Buckley E; Bolognesi DP; Lipp E; Schroeder K; Becher OJ; Friedman AH; McKay Z; Walter A; Threatt S; Jaggers D; Desjardins A; Gromeier M; Bigner DD; Ashley DM
    Lancet Child Adolesc Health; 2023 Jul; 7(7):471-478. PubMed ID: 37004712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
    Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
    J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a patient-specific algorithm for predicting distribution for convection-enhanced drug delivery into the brainstem of patients with diffuse intrinsic pontine glioma.
    Wembacher-Schroeder E; Kerstein N; Bander ED; Pandit-Taskar N; Thomson R; Souweidane MM
    J Neurosurg Pediatr; 2021 May; 28(1):34-42. PubMed ID: 33990084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
    Laetsch TW; DuBois SG; Mascarenhas L; Turpin B; Federman N; Albert CM; Nagasubramanian R; Davis JL; Rudzinski E; Feraco AM; Tuch BB; Ebata KT; Reynolds M; Smith S; Cruickshank S; Cox MC; Pappo AS; Hawkins DS
    Lancet Oncol; 2018 May; 19(5):705-714. PubMed ID: 29606586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
    Hipp SJ; Goldman S; Kaushal A; Krauze A; Citrin D; Glod J; Walker K; Shih JH; Sethumadhavan H; O'Neill K; Garvin JH; Glade-Bender J; Karajannis MA; Atlas MP; Odabas A; Rodgers LT; Peer CJ; Savage J; Camphausen KA; Packer RJ; Figg WD; Warren KE
    J Neurooncol; 2020 Sep; 149(3):437-445. PubMed ID: 33040274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery.
    Singleton WGB; Bienemann AS; Woolley M; Johnson D; Lewis O; Wyatt MJ; Damment SJP; Boulter LJ; Killick-Cole CL; Asby DJ; Gill SS
    J Neurosurg Pediatr; 2018 Sep; 22(3):288-296. PubMed ID: 29856296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma.
    Hollingworth M; Zacharoulis S
    J Neurooncol; 2022 Sep; 159(2):417-424. PubMed ID: 35933568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume.
    Singh R; Zhou Z; Tisnado J; Haque S; Peck KK; Young RJ; Tsiouris AJ; Thakur SB; Souweidane MM
    J Neurosurg Pediatr; 2016 Nov; 18(5):565-572. PubMed ID: 27391980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.